Merck (NYSE: MRK) and cCAM Biotherapeutics announced that the companies have signed a definitive agreement under which Merck will acquire ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE